NOROCLAV INJECTION FOR DOGS AND CATS

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:
AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE; CLAVULANIC ACID AS POTASSIUM CLAVULANATE
Available from:
NORBROOK LABORATORIES AUSTRALIA PTY LIMITED
INN (International Name):
amoxycillin as trihydrate(140mg/mL) + others
Pharmaceutical form:
PARENTERAL LIQUID/SOLUTION/SUSPENSION
Composition:
AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE ANTIBIOTIC Active 140.0 mg/ml; CLAVULANIC ACID AS POTASSIUM CLAVULANATE ANTIBIOTIC Active 35.0 mg/ml
Units in package:
10mL; 12 x 10mL; 12 x 50mL; 50mL
Class:
VM - Veterinary Medicine
Therapeutic group:
CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
Therapeutic area:
ANTIBIOTIC & RELATED
Therapeutic indications:
ACTINOBACILLUS LIGNIERESII | ACTINOMYCES BOVIS | BACILLUS ANTHRACIS | BACTEROIDES SPP. | BORDETELLA BRONCHISEPTICA | CAMPYLOBACTER SPP. | CLOSTRIDIUM SPP. | CORYNEBACTERIA | ESCHERICHIA COLI (E. COLI) | FUSOBACTERIUM NECROPHORUM | HAEMOPHILUS SPP. | KLEBSIELLA SPP. | MORAXELLA SPP. | PASTEURELLA SPP. | PEPTOSTREPTOCOCCUS SPP. | PROTEUS SPP. | SALMONELLA | STAPHYLOCOCCI | STREPTOCOCCI | ANAEROBIC BACTERIA | ANTHRAX | CANINE COUGH SYNDROME | CLOSTRIDIUM BOTULINUM | CLOSTRIDIUM CHAUVOEI | CLOSTRIDIUM FALLAX | CLOSTRIDIUM FESERI | CLOSTRIDIUM HEMOLYTICUM | CLOSTRIDIUM NOVYI | CLOSTRIDIUM PERFRINGENS TYPES | CLOSTRIDIUM SEPTICUM | CLOSTRIDIUM SORDELLI | CLOSTRIDIUM SPOROGENES | CLOSTRIDIUM TETANI | HAEMOPHILUS AGNI | HAEMOPHILUS BOVIS | HAEMOPHILUS PARAINFLUENZAE | HAEMOPHILUS PARASUIS | HAEMOPHILUS PLEUROPNEUMONIAE | HAEMOPHILUS SOMNUS | HAEMOPHILUS SUIS | INCLUDING B-LACTAMASE PRODUCIN | INFECTIOUS TRACHEOBRONCHITIS | PASTERELLOSIS | PASTEURELLOSIS | SALMONELLOSIS
Product summary:
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [ACTINOBACILLUS LIGNIERESII, ACTINOMYCES BOVIS, BACILLUS ANTHRACIS, BACTEROIDES SPP., BORDETELLA BRONCHISEPTICA, CAMPYLOBACTER SPP., CLOSTRIDIUM SPP., CORYNEBACTERIA, ESCHERICHIA COLI (E. COLI), FUSOBACTERIUM NECROPHORUM, HAEMOPHILUS SPP., KLEBSIELLA SPP., MORAXELLA SPP., PASTEURELLA SPP., PEPTOSTREPTOCOCCUS SPP., PROTEUS SPP., SALMONELLA, STAPHYLOCOCCI, STREPTOCOCCI]; DOG: [ACTINOBACILLUS LIGNIERESII, ACTINOMYCES BOVIS, BACILLUS ANTHRACIS, BACTEROIDES SPP., BORDETELLA BRONCHISEPTICA, CAMPYLOBACTER SPP., CLOSTRIDIUM SPP., CORYNEBACTERIA, ESCHERICHIA COLI (E. COLI), FUSOBACTERIUM NECROPHORUM, HAEMOPHILUS SPP., KLEBSIELLA SPP., MORAXELLA SPP., PASTEURELLA SPP., PEPTOSTREPTOCOCCUS SPP., PROTEUS SPP., SALMONELLA, STAPHYLOCOCCI, STREPTOCOCCI]; Ready-to-use broad spectrum antibiotic for dogs and cats.Do not use orally or parenterally in rabbits or guinea pigs. Use of this product may occasionally result in local tissue reaction.
Authorization status:
Registered
Authorization number:
52730
Authorization date:
2020-07-01

DRAFT VIAL LABEL TEXT

NOROCLAV Injection For Dogs and Cats

Text appearing above and below the header and footer lines is not included in the label.

24/01/01

Page 1 of 6

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

NOROCLAV INJECTION

For dogs and cats

AMOXYCILLIN (as trihydrate) 140 mg/mL

CLAVULANIC ACID (as potassium clavulanate) 35 mg/mL

10 mL/50 mL

[Norbrook logo]

Info

pest

Verified

DRAFT VIAL LABEL TEXT ANCILLARY PANEL

NOROCLAV Injection For Dogs and Cats

Text appearing above and below the header and footer lines is not included in the label.

24/01/01

Page 2 of 6

READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT

Store at 2-8

C (Refrigerate). Do not freeze.

Norbrook Laboratories Australia Pty Limited

NRA:

52730 / 0201

Exp.

DRAFT LEAFLET TEXT

NOROCLAV Injection For Dogs and Cats

Text appearing above and below the header and footer lines is not included in the label.

24/01/01

Page 3 of 6

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

NOROCLAV INJECTION

for Dogs and Cats

AMOXYCILLIN (as trihydrate) 140 mg/mL

CLAVULANIC ACID (as potassium clavulanate) 35 mg/mL

PRODUCT SUMMARY

Extended Spectrum of Activity - clavulanate extends the antibacterial spectrum of amoxycillin

by making it active against resistant (

-lactamase producing) strains of Staphylococci, E. coli,

Salmonella and Campylobacter species. Furthermore, Klebsiella species is added to the range

of susceptible species.

Kills Bacteria Rapidly - increases the likelihood of rapid clinical cure.

Excellent Absorption and Penetration - ensures sufficiently high levels of NOROCLAV

Injection to achieve clinical success.

Highly effective – the formulation of NOROCLAV Injection increases the high cure rtes

achieved with amoxycillin alone.

DESCRIPTION

NOROCLAV Injection for Dogs and Cats is an off-white suspension containing 140 mg/mL

amoxycillin as amoxycillin trihydrate (Ph. Eur) and 35 mg/mL clavulanic acid as potassium

clavulanate (Ph. Eur).

INDICATIONS

NOROCLAV Injection for Dogs and Cats has a notably broad spectrum of bactericidal activity

against the bacteria commonly found in dogs and cats.

Mode of Action – resistance to many antibiotics is caused by

-lactamase enzymes that

destroy the antibiotic before it can act on the bacteria themselves. The clavulanate in

NOROCLAV Injection for Dogs and Cats counteracts this defence mechanism by activating the

-lactamases, thus rendering the bacteria sensitive to amoxycillin’s rapid bacterial effect at

concentrations readily attainable in the body.

In vitro, NOROCLAV Injection is active against a wide range of clinically important bacteria,

including:

Gram-positive: Staphylococci (including

-lactamase producing strains), Streptococci,

Corynebacteria, Clostridium spp, Bacillus anthracis, Actinomyces bovis, Peptostreptococcus

spp.

Gram-negative: Escherichia coli (including

-lactamase producing strains), Salmonellae

(including

-lactamase producing strains), Bordetella bronchiseptica, Campylobacter spp,

Klebsiella spp, Proteus spp, Pasteurella spp, Fusobacterium necrophorum, Bacteroides

(including

-lactamase producing strains), Haemophilus spp, Moraxella spp and Actinobacillus

lignieresi.

DRAFT LEAFLET TEXT

NOROCLAV Injection For Dogs and Cats

Text appearing above and below the header and footer lines is not included in the label.

24/01/01

Page 4 of 6

Use of NOROCLAV Injection for Dogs and Cats has proved effective in the following conditions:

Respiratory tract infections, including tonsillitis, pharyngitis, bronchitis and pneumonia.

Urogenital tract infections, including cystitis, nephritis and metritis.

Skin and soft tissue infections, including abscesses, pyoderma, anal sacculitis and

gingivitis, septicaemia, post-parturient infections, etc.

DIRECTIONS FOR USE

Precautions:

In common with all other penicillins, NOROCLAV Injection for Dogs and Cats should not

be used orally or parenterally in rabbits or guinea pigs.

Shake well before use.

For subcutaneous or intramuscular injection only.

Water sensitive – use a dry syringe.

Use of this product may occasionally result in local tissue reaction.

Clavulanic acid is moisture sensitive. It is very important therefore that a completely dry

syringe is used when extracting suspension for injection in order to avoid contaminating

the remaining contents of the vial with drops of water. Contamination will result in

obvious beads of dark brown discolouration corresponding to the introduced water

droplets. Material affected in this way should not be used as it may have significantly

reduced potency.

Dogs and Cats: 8.75 mg combined active constituents/kg bodyweight, equivalent to 1 mL of

suspension per 20 kg bodyweight. Treatment should be administered once daily for 3 to 5 days.

Shake the vial to suspend the active material. Inject subcutaneously or intramuscularly, then

massage the injection site.

Dispose of empty container by wrapping with paper and putting in garbage.

NRA Approval No: 52730 / 0201

Storage:

Store at 2-8

C (Refrigerate). Do not freeze.

Presentation:

12 x 10 mL, 12 x 50 mL glass vials with nitryl bungs and aluminium seals.

Norbrook Laboratories Australia Pty Limited

A.C.N. 080 972 596

5/12 Ladd Road

New Gisborne, Vic, 3437

DRAFT CARTON TEXT MAIN PANEL

NOROCLAV Injection For Dogs and Cats

Text appearing above and below the header and footer lines is not included in the label.

24/01/01

Page 5 of 6

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

NOROCLAV INJECTION

for Dogs and Cats

Active Constituents: AMOXYCILLIN (as amoxycillin trihydrate) 140 mg/mL

CLAVULANIC ACID (as potassium clavulanate) 35 mg/mL

Ready-to-Use Broad Spectrum Antibiotic for Dogs and Cats

12 x 10 mL, 12 x 50 mL

[Norbrook logo]

DRAFT CARTON TEXT ANCILLARY PANEL

NOROCLAV Injection for Dogs and Cats

Text appearing above and below the header and footer lines is not included in the label.

24/01/01

Page 6 of 6

READ ENCLOSED LEAFLET BEFORE USING THIS PRODUCT

DIRECTIONS FOR USE

Precautions

Do not use in small herbivores such as rabbits or guinea pigs.

For subcutaneous or intramuscular injection only.

Use of the produce may occasionally result in local tissue reaction.

Dosage and administration

Use within 28 days of opening.

Shake well before use.

Water sensitive – use a dry syringe.

DOGS AND CATS: 8.75 mg/kg bodyweight once daily for 3.5 days. This is equivalent to 1 mL

per 20 kg bodyweight daily. The following is intended as a guide:

20 kg

5 kg

1 mL

0.25 mL

Norbrook Laboratories Australia Pty Limited

A.C.N. 080 972 596

5/12 Ladd Road

New Gisborne, Vic, 3437

Dispose of empty container by wrapping with paper and putting in garbage.

NRA Approval No: 52730 / 0201

Storage:

Store at 2-8

C (Refrigerate). Do not freeze.

Exp.

Product Name: Noroclav Injection for Dogs and Cats

Page: 1 of 4

This revision issued: September, 2009

MATERIAL SAFETY DATA SHEET

Issued by: Norbrook Laboratories Australia Pty Ltd

Freecall: 1800 665 866

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Section 1 - Identification of Chemical Product and Company

Norbrook Laboratories Australia Pty Ltd

Freecall: 1800 665 866

Unit 7/1 Trade Park Drive

Tullamarine, Vic 3043 AUSTRALIA

Substance:

Oil based antibiotic injection.

Trade Name:

Noroclav Injection for Dogs and Cats

APVMA Code:

52730

Product Use:

Broad spectrum antibiotic for use against the bacteria commonly found in dogs and

cats.

Creation Date:

September, 2009

This version issued:

September, 2009

and is valid for 5 years from this date.

Section 2 - Hazards Identification

Statement of Hazardous Nature

This product is classified as:

Not classified as hazardous according to the criteria of SWA.

Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code.

Risk Phrases:

Not Hazardous - No criteria found.

Safety Phrases:

S36, S24/25. Wear suitable protective clothing. Avoid contact with skin and eyes.

SUSDP Classification:

ADG Classification:

None allocated. Not a Dangerous Good under the ADG Code.

UN Number:

None allocated

Emergency Overview

Physical Description & Colour

: Off-white to cream coloured oily suspension.

Odour:

No odour.

Major Health Hazards:

no significant risk factors have been found for this product. This is an antibiotic preparation.

Any person with a history of allergies to this class of substances should avoid all contact with this product as it may

cause sensitisation. This is also a physiologically active product and so contact should be minimised, especially if the

user is taking a form of medication, as interactions can sometimes give unexpected and undesired results.

Potential Health Effects

Inhalation:

Short Term Exposure:

Available data indicates that this product is not harmful. In addition product is unlikely to

cause any discomfort or irritation.

Long Term Exposure:

No data for health effects associated with long term inhalation.

Skin Contact:

Short Term Exposure:

Available data indicates that this product is not harmful. It should present no hazards in

normal use. However product may be irritating, but is unlikely to cause anything more than mild transient discomfort.

Long Term Exposure:

No data for health effects associated with long term skin exposure.

Eye Contact:

Short Term Exposure

: This product may be mildly irritating to eyes, but is unlikely to cause anything more than

mild discomfort which should disappear once product is removed.

Long Term Exposure

: No data for health effects associated with long term eye exposure.

Ingestion:

Short Term Exposure

: Significant oral exposure is considered to be unlikely. However, this product may be

irritating to mucous membranes but is unlikely to cause anything more than transient discomfort.

Long Term Exposure

: No data for health effects associated with long term ingestion.

Carcinogen Status:

SWA:

No significant ingredient is classified as carcinogenic by SWA.

NTP:

No significant ingredient is classified as carcinogenic by NTP.

IARC:

No significant ingredient is classified as carcinogenic by IARC.

Product Name: Noroclav Injection for Dogs and Cats

Page: 2 of 4

This revision issued: September, 2009

MATERIAL SAFETY DATA SHEET

Issued by: Norbrook Laboratories Australia Pty Ltd

Freecall: 1800 665 866

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Section 3 - Composition/Information on Ingredients

Ingredients

CAS No

Conc,%

TWA (mg/m

3

)

STEL (mg/m

3

)

Amoxycyllin (as trihydrate)

61336-70-7

140mg/mL

not set

not set

Clavulanic acid (as potassium salt)

61177-45-5

35mg/mL

not set

not set

Other non hazardous ingredients

secret

to 100

not set

not set

This is a commercial product whose exact ratio of components may vary slightly. Minor quantities of other non

hazardous ingredients are also possible.

The SWA TWA exposure value is the average airborne concentration of a particular substance when calculated over a normal 8 hour working day

for a 5 day working week. The STEL (Short Term Exposure Limit) is an exposure value that may be equalled (but should not be exceeded) for no

longer than 15 minutes and should not be repeated more than 4 times per day. There should be at least 60 minutes between successive exposures

at the STEL. The term "peak "is used when the TWA limit, because of the rapid action of the substance, should never be exceeded, even briefly.

Section 4 - First Aid Measures

General Information:

You should call The Poisons Information Centre if you feel that you may have been poisoned, burned or irritated by

this product. The number is 13 1126 from anywhere in Australia (0800 764 766 in New Zealand) and is available at all

times. Have this MSDS with you when you call.

Self Injection: Accidental self injection may lead to an inflammatory response. Medical advice should be sought on

the management of deep injections, particularly those near a joint or associated with bruising. If possible the

application of gentle squeezing pressure with absorbent material (e.g. facial tissues) at the injection site will swab up

unabsorbed vaccine. Strong squeezing of the site should be avoided. The damaged area should be thoroughly

cleansed and a topical antiseptic applied. Check your tetanus immunisation status.

Inhalation:

First aid is not generally required. If in doubt, contact a Poisons Information Centre or a doctor.

Skin Contact:

Gently blot away excess liquid. Wash gently and thoroughly with water (use non-abrasive soap if

necessary) for 5 minutes or until chemical is removed.

Eye Contact:

Quickly and gently blot material from eyes. No effects expected. If irritation does occur, flush

contaminated eye(s) with lukewarm, gently flowing water for 5 minutes or until the product is removed. Obtain medical

advice if irritation becomes painful or lasts more than a few minutes. Take special care if exposed person is wearing

contact lenses.

Ingestion:

If product is swallowed or gets in mouth, do NOT induce vomiting; wash mouth with water and give some

water to drink. If symptoms develop, or if in doubt contact a Poisons Information Centre or a doctor.

Section 5 - Fire Fighting Measures

Fire and Explosion Hazards

: There is no risk of an explosion from this product under normal circumstances if it is

involved in a fire. Violent steam generation or eruption may occur upon application of direct water stream on hot

liquids.

Only small quantities of decomposition products are expected from this products at temperatures normally achieved in

a fire. This will only occur after heating to dryness.

Fire decomposition products from this product are not expected to be hazardous or harmful.

Extinguishing Media

: Not Combustible. Use extinguishing media suited to burning materials.

Fire Fighting

: No special firefighting measures are thought necessary for this product.

Flash point

:

No data.

Upper Flammability Limit:

No data.

Lower Flammability Limit:

No data.

Autoignition temperature:

No data.

Flammability Class:

No data.

Section 6 - Accidental Release Measures

Accidental release

: This product is sold in small packages, and the accidental release from one of these is not

usually a cause for concern. For minor spills, refer to product label for specific instructions. No special protective

clothing is normally necessary because of this product. However it is good practice to wear latex gloves when

handling injectables. In the event of a major spill, prevent spillage from entering drains or water courses and call

emergency services.

Section 7 - Handling and Storage

Handling

: Keep exposure to this product to a minimum, and minimise the quantities kept in work areas. Check

Section 8 of this MSDS for details of personal protective measures, and make sure that those measures are followed.

Product Name: Noroclav Injection for Dogs and Cats

Page: 3 of 4

This revision issued: September, 2009

MATERIAL SAFETY DATA SHEET

Issued by: Norbrook Laboratories Australia Pty Ltd

Freecall: 1800 665 866

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

The measures detailed below under "Storage" should be followed during handling in order to minimise risks to

persons using the product in the workplace. Also, avoid contact or contamination of product with incompatible

materials listed in Section 10.

Storage

: This product is a Scheduled Poison. Observe all relevant regulations regarding sale, transport and storage

of this schedule of poison. Refrigerate, preferably between 2 and 8°C, but do not freeze. Store in the closed original

container in a dry, cool, well-ventilated area out of direct sunlight. Make sure that the product does not come into

contact with substances listed under "Incompatibilities" in Section 10. Some liquid preparations settle or separate on

standing and may require stirring before use. Check packaging - there may be further storage instructions on the

label.

Section 8 - Exposure Controls and Personal Protection

The following Australian Standards will provide general advice regarding safety clothing and equipment:

Respiratory equipment: AS/NZS 1715, Protective Gloves: AS 2161, Industrial Clothing: AS2919, Industrial Eye

Protection: AS1336 and AS/NZS 1337, Occupational Protective Footwear: AS/NZS2210.

SWA Exposure Limits

TWA (mg/m

3

)

STEL (mg/m

3

)

Exposure limits have not been established by SWA for any of the significant ingredients in this product.

The ADI for Amoxycyllin is set at 0.2mg/kg/day. The corresponding NOEL is set at 200mg/kg/day.

The ADI for Clavulanic acid is set at 0.01mg/kg/day. The corresponding NOEL is set at 10mg/kg/day. ADI means

Acceptable Daily Intake; NOEL means No-observable-effect-level. Taken from Australian ADI List, Dec 2008.

No special equipment is usually needed when occasionally handling small quantities. The following instructions are

for bulk handling or where regular exposure in an occupational setting occurs without proper containment systems.

Ventilation:

No special ventilation requirements are normally necessary for this product. However make sure that

the work environment remains clean and that vapours and mists are minimised.

Eye Protection:

Eye protection is not normally necessary when this product is being used. However, if in doubt,

wear suitable protective glasses or goggles.

Skin Protection:

You should avoid contact even with mild skin irritants. Therefore you should wear suitable

impervious elbow-length gloves and facial protection when handling this product. See below for suitable types.

Protective Material Types:

We suggest that protective clothing be made from the following materials: latex.

Respirator:

Usually, no respirator is necessary when using this product. However, if you have any doubts consult

the Australian Standard mentioned above.

Safety deluge showers should, if practical, be provided near to where this product is being used.

Section 9 - Physical and Chemical Properties:

Physical Description & colour

Off-white to cream coloured oily suspension.

Odour:

No odour.

Boiling Point:

Not available.

Freezing/Melting Point:

No specific data. Liquid at normal temperatures.

Volatiles:

Water component.

Vapour Pressure:

No data.

Vapour Density:

No data.

Specific Gravity:

0.988

Water Solubility:

Insoluble.

pH:

No data; expected to be near neutral.

Volatility:

No data.

Odour Threshold:

No data.

Evaporation Rate:

No data.

Coeff Oil/water Distribution

No data

Autoignition temp:

No data.

Section 10 - Stability and Reactivity

Reactivity:

This product is unlikely to react or decompose under normal storage conditions. However, if you have

any doubts, contact the supplier for advice on shelf life properties.

Conditions to Avoid:

Refrigerate, preferably between 2 and 8°C, but do not freeze. Store in the closed original

container in a dry, cool, well-ventilated area out of direct sunlight.

Incompatibilities:

No particular Incompatibilities.

Fire Decomposition:

Only small quantities of decomposition products are expected from this products at

temperatures normally achieved in a fire. This will only occur after heating to dryness. Carbon dioxide, and if

combustion is incomplete, carbon monoxide and smoke. Nitrogen and its compounds, and under some

Product Name: Noroclav Injection for Dogs and Cats

Page: 4 of 4

This revision issued: September, 2009

MATERIAL SAFETY DATA SHEET

Issued by: Norbrook Laboratories Australia Pty Ltd

Freecall: 1800 665 866

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

circumstances, oxides of nitrogen. Occasionally hydrogen cyanide gas in reducing atmospheres. Oxides of sulfur

(sulfur dioxide is a respiratory hazard) and other sulfur compounds. Most will have a foul odour. Hydrogen chloride

gas, other compounds of chlorine. Water, potassium compounds. Carbon monoxide poisoning produces headache,

weakness, nausea, dizziness, confusion, dimness of vision, disturbance of judgment, and unconsciousness followed

by coma and death.

Polymerisation:

This product will not undergo polymerisation reactions.

Section 11 - Toxicological Information

Local Effects:

Target Organs:

There is no data to hand indicating any particular target organs.

Classification of Hazardous Ingredients

Ingredient

Risk Phrases

No ingredient mentioned in the HSIS Database is present in this product at hazardous concentrations.

Section 12 - Ecological Information

Insufficient data to be sure of status. Expected to not be an environmental hazard.

Section 13 - Disposal Considerations

Disposal:

Dispose of small quantities and empty containers by wrapping with paper and putting in garbage.

Discarded needles should immediately be placed in a designated and appropriately labelled sharps container. For

larger quantities, if recycling or reclaiming is not possible, use a commercial waste disposal service.

Section 14 - Transport Information

ADG Code:

This product is not classified as a Dangerous Good. No special transport conditions are necessary

unless required by other regulations.

Section 15 - Regulatory Information

AICS:

All of the significant ingredients in this formulation are compliant with NICNAS regulations.

The following ingredients: Amoxycyllin, Clavulanic acid, are mentioned in the SUSDP.

Section 16 - Other Information

This MSDS contains only safety-related information. For other data see product literature.

Acronyms:

ADG Code

Australian Code for the Transport of Dangerous Goods by Road and Rail (7

edition)

AICS

Australian Inventory of Chemical Substances

SWA

Safe Work Australia, formerly ASCC and NOHSC

CAS number

Chemical Abstracts Service Registry Number

IARC

International Agency for Research on Cancer

NTP

National Toxicology Program (USA)

R-Phrase

Risk Phrase

SUSDP

Standard for the Uniform Scheduling of Drugs & Poisons

UN Number

United Nations Number

THIS MSDS SUMMARISES OUR BEST KNOWLEDGE OF THE HEALTH AND SAFETY HAZARD INFORMATION OF THE PRODUCT AND

HOW TO SAFELY HANDLE AND USE THE PRODUCT IN THE WORKPLACE. EACH USER MUST REVIEW THIS MSDS IN THE CONTEXT OF

HOW THE PRODUCT WILL BE HANDLED AND USED IN THE WORKPLACE.

IF CLARIFICATION OR FURTHER INFORMATION IS NEEDED TO ENSURE THAT AN APPROPRIATE RISK ASSESSMENT CAN BE MADE,

THE USER SHOULD CONTACT THIS COMPANY SO WE CAN ATTEMPT TO OBTAIN ADDITIONAL INFORMATION FROM OUR SUPPLIERS

OUR RESPONSIBILITY FOR PRODUCTS SOLD IS SUBJECT TO OUR STANDARD TERMS AND CONDITIONS, A COPY OF WHICH IS SENT

TO OUR CUSTOMERS AND IS ALSO AVAILABLE ON REQUEST.

Please read all labels carefully before using product.

This MSDS is prepared in accord with the SWA document “National Code of Practice for the Preparation of

Material Safety Data Sheets” 2nd Edition [NOHSC:2011(2003)]

Copyright © Kilford & Kilford Pty Ltd, September, 2009.

http://www.kilford.com.au/

Phone (02)9251 4532

Similar products

Search alerts related to this product

View documents history

Share this information